CU20060121A7 - TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS - Google Patents
TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORSInfo
- Publication number
- CU20060121A7 CU20060121A7 CU20060121A CU20060121A CU20060121A7 CU 20060121 A7 CU20060121 A7 CU 20060121A7 CU 20060121 A CU20060121 A CU 20060121A CU 20060121 A CU20060121 A CU 20060121A CU 20060121 A7 CU20060121 A7 CU 20060121A7
- Authority
- CU
- Cuba
- Prior art keywords
- hormones
- patch
- potentiators
- transdermal administration
- need
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
La invención se refiere a un parche que comprende una capa de droga con un bajo contenido de hormonas, como por ejemplo gestodeno, y opcionalmente un estrógeno (por ejemplo etinilestradiol). Al aplicar el parche a una mujer, se consiguen niveles de plasma de al menos 1,0 ng / ml de gestodeno en condiciones de estado estacionario sin necesidad de incorporar potenciadores de penetración ni mejoradores de permeación en la capa que contiene droga. También son satisfactorios los niveles en plasma de las hormonas que se consiguen durante todo un período de al menos 1 semana, haciendo que el parche se pueda aplicar para utilizarlo en anticoncepción femenina con el concepto de aplicar el parche una vez a la semana.The invention relates to a patch comprising a drug layer with a low content of hormones, such as, for example, signodene, and optionally an estrogen (for example ethinyl estradiol). By applying the patch to a woman, plasma levels of at least 1.0 ng / ml of signodene are achieved under steady state conditions without the need to incorporate penetration enhancers or permeation enhancers in the drug-containing layer. Plasma levels of hormones that are achieved over a period of at least 1 week are also satisfactory, making the patch can be applied for use in female contraception with the concept of applying the patch once a week.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060121A CU23649B7 (en) | 2006-06-09 | 2006-06-09 | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060121A CU23649B7 (en) | 2006-06-09 | 2006-06-09 | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20060121A7 true CU20060121A7 (en) | 2008-06-30 |
CU23649B7 CU23649B7 (en) | 2011-04-26 |
Family
ID=44280800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20060121A CU23649B7 (en) | 2006-06-09 | 2006-06-09 | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS |
Country Status (1)
Country | Link |
---|---|
CU (1) | CU23649B7 (en) |
-
2006
- 2006-06-09 CU CU20060121A patent/CU23649B7/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CU23649B7 (en) | 2011-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8465A (en) | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS | |
CU20100143A7 (en) | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS | |
Paudel et al. | Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers | |
CY1120878T1 (en) | INTRACTIVE ADMINISTRATION SYSTEM FOR CONTRACTING | |
MX2022008277A (en) | Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof. | |
ATE496617T1 (en) | CONTROLLED RELEASE DELIVERY SYSTEM FOR NASAL USE OF NEUROTRANSMITTERS | |
MX2018011706A (en) | Steroid hormone pharmaceutical composition. | |
AR048878A1 (en) | TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE | |
SE0202857D0 (en) | Method and compositions for preventing hormone induced adverse effects | |
DE602005026290D1 (en) | COMPOSITIONS OF DELAYED RELEASE WITH PROGESTERONE RECEPTOR MODULATORS | |
NI201700173A (en) | DROSPIRENONE-BASED CONTRACEPTIVES FOR FEMALE PATIENT AFFECTED WITH EXCESS OF WEIGHT | |
PH12018550210A1 (en) | Oral dosage form with drug composition, barrier layer and drug layer | |
CL2007002000A1 (en) | Pharmaceutical preparation for oral administration with controlled release of active ingredient in the small intestine comprising inert carriers, active ingredients, an inner layer composed of 2 diffusion layers to control the release and a gastro-resistant layer; Preparation method. | |
CR8059A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES | |
AR095691A1 (en) | FORMULATION OF AMORFO L-5-METHYLETHYDROPHOLATE (L-5-MTHF-Ca), PROCEDURE, USE | |
AR111649A1 (en) | VAGINAL RING FOR THE SIMULTANEOUS RELEASE OF TWO ACTIVE INGREDIENTS | |
ATE382356T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ESTETROL DERIVATIVES AND USE IN CANCER TREATMENT | |
PE20120956A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING BUPRENORPHINE AND NALMEFENE | |
PE20070119A1 (en) | NEW REGIMES FOR CONTROLLED DELIVERY DEVICES FOR CONTRACEPTION DRUGS | |
CU20060121A7 (en) | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS | |
UY28668A1 (en) | TRANSDERMAL ADMINISTRATION HORMONES THAT DO NOT NEED PENETRATION POTENTIATORS | |
HN2010000081A (en) | STRATRIENS 8-BETA-SUBSTITUTED AS SELECTIVE ACTION STROGENS | |
BR112014018426A8 (en) | COMPOSITION AND DEVICE FOR TRANSDERMAL ADMINISTRATION, AND METHOD FOR ADMINISTERING A PROGESTIN | |
WO2012031999A3 (en) | Low-dose transdermal patches with high drug release | |
UA41798U (en) | Method for selecting donor cows and recipient heifers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent |